Max Healthcare Institute Ltd
NSE: MAXHEALTH BSE: 543220
₹921
+25.50 (2.85%)
Sat, 07 Nov 2026, 10:03 pm
Market Cap (in Cr)85953.03
PE Ratio65.18
Dividend0.23
Max Healthcare Institute Analysis
dividend
Pros
Cons
- Unable to evaluate Max India's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Max India's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
Pros
Cons
- Max India's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Debt is not well covered by operating cash flow (8.6%, less than 20% of total debt).
- Debt is not covered by short term assets, assets are 0.4x debt.
- Max India's long term commitments exceed its cash and other short term assets.
- The level of debt compared to net worth has increased over the past 5 years (85.2% vs 103.8% today).
- Max India is making a loss, therefore interest payments are not well covered by earnings.
- Max India's level of debt (103.8%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
Pros
- The tenure for the Max India management team is about average.
Cons
misc
Pros
Cons
- Max India is not covered by any analysts.
- Max India's last earnings update was 399 days ago.
past
Pros
Cons
- Unable to compare Max India's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Max India does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
- Max India used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
- It is difficult to establish if Max India improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Max India has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Max India's 1-year growth to the IN Healthcare industry average as it is not currently profitable.
value
Pros
Cons
- Max India is overvalued based on assets compared to the IN Healthcare industry average.
- Max India is loss making, we can't compare its value to the IN Healthcare industry average.
- Max India is loss making, we can't compare the value of its earnings to the India market.